secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2025-12-11T23:59:59+00:00
Accession:  0001493152-25-027167
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ernexa Therapeutics posts new investor presentation; details not disclosed in filing
--------------------------------------------------------------------------------

- Company made a December 2025 investor presentation available via 8-K and its website.
- No financial or operational data from the presentation is included in the filing.
- Investors will need to access the company website to view the presentation content.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000149315225027167/0001493152-25-027167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000149315225027167/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-027167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer